Therapy-induced tumour secretomes promote resistance and tumour progression.
View / Open Files
Authors
Shu, Weiping
Kong, Xiangju
Bosenberg, Marcus C
Rosen, Neal
Lo, Roger S
Publication Date
2015-04Journal Title
Nature
ISSN
0028-0836
Volume
520
Issue
7547
Pages
368-372
Language
eng
Type
Article
This Version
AM
Physical Medium
Print-Electronic
Metadata
Show full item recordCitation
Obenauf, A. C., Zou, Y., Ji, A. L., Vanharanta, S., Shu, W., Shi, H., Kong, X., et al. (2015). Therapy-induced tumour secretomes promote resistance and tumour progression.. Nature, 520 (7547), 368-372. https://doi.org/10.1038/nature14336
Keywords
Cell Line, Tumor, Clone Cells, Animals, Humans, Mice, Melanoma, Adenocarcinoma, Lung Neoplasms, Neoplasm Metastasis, Disease Progression, Proto-Oncogene Proteins B-raf, Receptor Protein-Tyrosine Kinases, Proto-Oncogene Proteins c-fos, Protein Kinase Inhibitors, Signal Transduction, Cell Proliferation, Cell Movement, Cell Survival, Down-Regulation, Enzyme Activation, Drug Resistance, Neoplasm, Female, Proto-Oncogene Proteins c-akt, Metabolome, Tumor Microenvironment, ErbB Receptors, Anaplastic Lymphoma Kinase
Sponsorship
Medical Research Council (MC_UU_12022/7)
Identifiers
External DOI: https://doi.org/10.1038/nature14336
This record's URL: https://www.repository.cam.ac.uk/handle/1810/302059
Rights
All rights reserved